CML treatment results in Slovenia in the era of tirozin kinaze inhibitors

CML treatment results in Slovenia in the era of tirozin kinaze inhibitors

Background: Chronic myeloid leukemia (CML) is a malignant myeloproliferative disorder of hematopoietic stem cells. It is the first malignancy with a known specific chromosomal abnormality, the Philadelphia (Ph) chromosome t(9;22) (q34;q11), which has become a model in the research and treatment of m...

Full description

Bibliographic Details
Main Authors: Irena Preložnik Zupan, Tadej Pajič, Marjana Glaser, Tatjana Grmek Zemljič, Mateja Grat, Nataša Fikfak, Irena Bricman, Marija Čeh, Vlasta Petric, Milica Skamagkoulis
Format: Article
Language:English
Published: Slovenian Medical Association 2012-12-01
Series:Zdravniški Vestnik
Online Access:http://vestnik.szd.si/index.php/ZdravVest/article/view/739

Internet

http://vestnik.szd.si/index.php/ZdravVest/article/view/739

Similar Items